|
May 13
|
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
|
|
May 9
|
Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
|
|
May 8
|
Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
|
|
May 8
|
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
|
|
May 6
|
Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
|
|
Apr 9
|
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
|
|
Mar 28
|
Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now
|
|
Mar 19
|
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 13
|
11 Oversold NASDAQ Stocks To Buy Right Now
|
|
Mar 13
|
11 Oversold Healthcare Stocks To Buy Right Now
|
|
Mar 7
|
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
|
|
Mar 6
|
Q4 2023 Seres Therapeutics Inc Earnings Call
|
|
Mar 5
|
Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023
|
|
Mar 5
|
Seres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
|
|
Jan 9
|
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
|
|
Jan 4
|
Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 8
|
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
|
|
Dec 2
|
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a favorite amongst institutional investors who own 62%
|
|
Nov 28
|
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
|